Earlier administration of high-dose bolus tirofiban in STEMI increases benefit without increasing bleeding complications

被引：0

作者：

不详

机构：

来源：

CARDIOVASCULAR JOURNAL OF AFRICA | 2009年 / 20卷 / 04期

关键词：

ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL; ANGIOPLASTY; ABCIXIMAB;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The most recently announced multi-strategy trial also supported the view that the high-dose bolus regimen of tirofiban was as efficacious as abciximab, while resulting in a numerically lower incidence of complications and significantly lower incidences of thrombocytopenia.

引用

页码：268 / +

页数：2

共 50 条

[41] Induction of natural killer suppressive factor in murine peritoneal cavity by intraperitoneal bolus administration of high-dose cisplatin
Ishikawa K.
Shimoda K.
Shiraishi N.
Adachi Y.
Kitano S.
International Journal of Clinical Oncology, 2000, 5 (1) : 48 - 53
[42] Thrombotic complications following the administration of high-dose prothrombin complex concentrate for acute warfarin reversal
Zemrak, Wesley R.
Kelley, Erin
Kovacic, Nicole L.
Mooney, Deirdre M.
Morris, Jane G.
MacVane, Casey Z.
Rosenblatt, Jeffrey A.
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2016, 34 (08): : 1736.e1 - 1736.e3
[43] Benefit/risk profile of high-dose antithrombin in patients with severe sepsis treated with and without concomitant heparin
Hoffmann, Johannes N.
Wiedermann, Christian J.
Juers, Mathias
Ostermann, Helmut
Kienast, Joachim
Briege, Josef
Strauss, Richard
Warren, Brian L.
Opal, Steven M.
THROMBOSIS AND HAEMOSTASIS, 2006, 95 (05) : 850 - 856
[44] Tirofiban, administered at high dose bolus during coronary angioplasty is highly effective in preventing periprocedural ischemic complications in diabetic patients. Insights into the ADVANCE trial
Valgimigli, M
Percoco, G
Ferrari, F
Barbieri, D
Campo, G
Malagutti, P
Cicchitelli, G
Guardigli, G
Agostoni, P
Ferrari, R
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 62A - 63A
[45] Gastrointestinal Bleeding Secondary to High-Dose Melphalan Pretreatment in Patients with Multiple Myeloma Was Associated with the Mode of Melphalan Administration
Ge, Qunfang
Wang, Yi
Zhu, Huiling
Xu, Kaihong
Sheng, Lixia
Yan, Xiaoyan
Ouyang, Guifang
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
[46] High-dose oral proton pump inhibitor is as effective as intravenous administration in the aspect of increasing intragastric pH and reducing rebleeding after endoscopic treatment of bleeding peptic ulcers
Jang, Jae-Young
Dong, Seek Ho
Jung, Ji Heon
Chae, Myung Jong
Kim, Nam Hoon
Lee, Sang Kil
Joo, Kwang Ro
Kim, Hyo Jong
Kim, Byung-Ho
Chang, Young-Woon
Lee, Joung Il
Chang, Rin
GASTROENTEROLOGY, 2006, 130 (04) : A467 - A467
[47] Administration of high-dose macrophage colony-stimulating factor increases bone turnover and trabecular volume fraction
Shane A. Lloyd
Yuyu Y. Yuan
Steven J. Simske
Stephanie E. Riffle
Virginia L. Ferguson
Ted A. Bateman
Journal of Bone and Mineral Metabolism, 2009, 27 : 546 - 554
[48] Administration of high-dose macrophage colony-stimulating factor increases bone turnover and trabecular volume fraction
Lloyd, Shane A.
Yuan, Yuyu Y.
Simske, Steven J.
Riffle, Stephanie E.
Ferguson, Virginia L.
Bateman, Ted A.
JOURNAL OF BONE AND MINERAL METABOLISM, 2009, 27 (05) : 546 - 554
[49] High-dose antioxidant administration is associated with a reduction in post-injury complications in critically ill trauma patients
Giladi, Aviram M.
Dossett, Lesly A.
Fleming, Sloan B.
Abumrad, Naji N.
Cotton, Bryan A.
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2011, 42 (01): : 78 - 82
[50] Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high-dose vs. low-dose heparin protocols
Hanslik, A.
Kitzmueller, E.
Thom, K.
Haumer, M.
Mlekusch, W.
Salzer-Muhar, U.
Michel-Behnke, I.
Male, C.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (12) : 2353 - 2360

← 1 2 3 4 5 →